EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic

Veronika Bachanova, Michael R Bishop, Parastoo Dahi, Bhagirathbhai Dholaria, Stephan A Grupp, Brandon Hayes-Lattin, Murali Janakiram, Richard T Maziarz, Joseph P McGuirk, Loretta J Nastoupil, Olalekan O Oluwole, Miguel-Angel Perales und 3 weitere

Biology of Blood and Marrow Transplantation · 2020-07 · 26 (7) · 1239-1246

DOI: 10.1016/j.bbmt.2020.04.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biology of Blood and Marrow Transplantation, 2020-07. Verfasst von Veronika Bachanova und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN. Hauptthemen laut MEDLINE: Pandemics. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PandemicsAntibodies, Monoclonal, HumanizedCOVID-19Communicable Disease ControlCoronavirus InfectionsHealth Care RationingHumansImmunotherapy, AdoptiveLymphoma, B-CellPneumonia, ViralPractice Guidelines as TopicPrecursor B-Cell Lymphoblastic Leukemia-LymphomaReceptors, Antigen, T-CellReceptors, Chimeric AntigenT-LymphocytesTissue DonorsUnited States

Stichwörter der Autor:innen

COVID-19Cellular therapyChimeric antigen receptor T cellsCoronavirusPandemic

Substanzen

Antibodies, Monoclonal, HumanizedReceptors, Antigen, T-CellReceptors, Chimeric Antigentocilizumab

Autor:innen und Institutionen

  • Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN.
  • Hematopoietic Cellular Therapy Program, Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL.
  • Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY.
  • Division of Hematology Oncology, Department of Medicine, Vanderbilt School of Medicine, Nashville, TN.
  • Section of Cellular Therapy and Transplant, Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Knight Cancer Institute, Oregon Health & Science University, Portland, OR.

Förderung

  • NCI NIH HHS
  • National Cancer Center

Zitieren

APA

Bachanova, V., Bishop, M. R., Dahi, P., Dholaria, B., Grupp, S. A., Hayes-Lattin, B., Janakiram, M., Maziarz, R. T., McGuirk, J. P., Nastoupil, L. J., Oluwole, O. O., Perales, M. A., Porter, D. L., Riedell, P. A., & CAR T-cell Consortium (2020). Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic. Biology of Blood and Marrow Transplantation, 26(7), 1239-1246. https://doi.org/10.1016/j.bbmt.2020.04.008

Vancouver

Bachanova V, Bishop MR, Dahi P, Dholaria B, Grupp SA, Hayes-Lattin B, et al. Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic. Biology of Blood and Marrow Transplantation. 2020;26(7):1239-1246. doi:10.1016/j.bbmt.2020.04.008

BibTeX
@article{Bachanova2020,
  author = {Bachanova, Veronika and Bishop, Michael R and Dahi, Parastoo and Dholaria, Bhagirathbhai and Grupp, Stephan A and Hayes-Lattin, Brandon and Janakiram, Murali and Maziarz, Richard T and McGuirk, Joseph P and Nastoupil, Loretta J and Oluwole, Olalekan O and Perales, Miguel-Angel and Porter, David L and Riedell, Peter A and CAR T-cell Consortium, CAR T-cell Consortium},
  title = {Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic},
  journal = {Biology of Blood and Marrow Transplantation},
  year = {2020},
  volume = {26},
  number = {7},
  pages = {1239--1246},
  doi = {10.1016/j.bbmt.2020.04.008}
}
Kostenlos starten →